The growing interest in potent weight management has spurred considerable exploration into novel treatments. Currently, Retatrutide, a twin-action GIP and glucagon-like peptide-1 (GLP-1) receptor stimulator, has shown promising results in clinical trials, indicating potential for significant weight decrease. Therefore, numerous individuals are seek